English
  • Brensocatib

    Brensocatib

    API’s Name CAS No. US DMF Patent Expiry Date (US) Current Status 
    Brensocatib 2923839-30-7 Mar, 2027  Mar.12, 2035 estimated PV Completion – Dec, 2026

     

    [Indication] 

    For the treatment of non-cystic fibrosis bronchiectasis (NCFB) in patients 12 years of age and older.

    inquirydetail
  • Bictegravir

    Bictegravir

    API’s Name CAS No. US DMF Patent Expiry Date (US) Current status
    Bictegravir  1611493-60-7 ✓ Dec.19, 2033 PV Completion

     

    [Indication]

    For the treatment of human immunodeficiency virus type 1 (HIV-1) infection as a complete regimen for adults.

    inquirydetail
  • Baloxavir Marboxil

    Baloxavir Marboxil

    API’s Name CAS No. US DMF Patent Expiry Date (US) Current status
    Baloxavir Marboxil 1985606-14-1  36657 Apr.27, 2036 PV Completion

     

    [Indication]

    1. For the treatment of acute uncomplicated influenza in patients 5 years and older who have been symptomatic for no more than 48 hours.

    2. For post-exposure prophylaxis of influenza in people 5 years and older.

    inquirydetail